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ABSTRACT
Analysis of Ghrelin Concentrations in Serum
Samples Processed at One, Two, and
Three Hours after Collection
by
Christine Prato
Dr. Mark Buttner, Examination Committee Chair
Associate Professor of Environmental and Occupational Health
University of Nevada, Las Vegas

Obesity is becoming an epidemic of modern society. While the health-related
consequences of obesity have been well studied, scientists continue to search for
biological risk factors associated with this disease. Since the 1999 discovery of an
appetite-stimulating hormone, ghrelin, researchers have further questioned the
physiological interactions that lead to obesity. The fundus of the stomach, as well as the
intestines and kidneys produce ghrelin before it circulates throughout the body and
attaches to its receptor sites located within the section of the brain responsible for
appetite-regulation. The hormone increases and decreases in a circadian rhythm that may
dictate the routine human eating patterns of breakfast, lunch and dinner.
While the field of ghrelin research continues to grow as evidenced by the
increasing number of published articles, the majority of the ghrelin research occurs in the
laboratory setting. This environment has provided researchers with the preservation and
storage techniques necessary to analyze ghrelin. For example, the current Millipore
Human Ghrelin (Total) ELISA kit protocol for measuring ghrelin requires the collected
blood be centrifuged thirty minutes after collection and immediately placed in a freezer.
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This limitation alone may impede researchers wishing to conduct clinical research
because these requirements are frequently not possible.
The objectives of this study were to determine the optimal storage time before
processing blood samples collected in the clinical setting to ensure the preservation of
ghrelin and to conclude whether a change in the manufacturer’s protocol was warranted.
By comparing blood samples processed according to the Millipore ELISA kit
protocol to samples stored for one, two, and three hours, it was determined that mean
ghrelin concentrations at thirty minutes, one hour and two hour were not significantly
different, suggesting that the current Millipore ELISA protocol of thirty minutes can be
extended for a period of up to two hours.
When the crude model was adjusted to include the variables time, waist
circumference and exercise, the statistically significant variables in previous ANOVA
models, the presence or absence of an exercise routine was found to have the strongest
association to mean ghrelin concentrations. These findings will facilitate the experimental
design of research aimed at studying ghrelin levels in individuals outside of the
laboratory setting, and can also support new research analyzing the effect of exercise on
ghrelin levels.
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CHAPTER 1
INTRODUCTION
Obesity is the second leading cause of preventable death in the U.S. and it is
estimated that almost 100 million adults in this country have a body mass index over 25
(CDC, 2002). Combating obesity has been a main objective of the CDC for several years.
As part of the Healthy People 2010 initiative, the CDC hoped that obesity rates would
decrease to 15% of the population in each state; however, no state met that objective
(CDC, 2009). The causes of obesity can be subdivided into environmental and biological
factors. A decrease in physical exercise combined with a high caloric intake accounts for
the majority of obesity cases. However, biological factors such as metabolic disorders
like Prader-Willi syndrome, and imbalances in the various proteins that surround food
intake and digestion, if not managed properly, can also lead to obesity.
This disease is also of great concern for public health officials since it is often
cited for the great number of associated co-morbidities. Cardiovascular disease, Type II
diabetes, certain types of cancer, and sleep apnea can all result from being obese (Bray,
2004). The direct medical costs associated with obesity are staggering. The impact of
obese patients seeking medical attention stresses the US healthcare system since an obese
patient can require the care of numerous physicians, while being prescribed various
medications. This utilization of the available healthcare resources due to obesity cost
$147 billion in 2008 (Hammond, 2010). However, the consequences of obesity are not
just limited to health related outcomes; it also places strain on other aspects of daily life.
In addition to the direct medical costs associated with this disease, obesity affects
the nation by causing loss of productivity, human capital, and increasing the cost of
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transportation (Hammond, 2010). While members of the population who are normal
weight may not currently be affected by the increasing levels of obesity in the nation, the
stresses that obesity places on the infrastructure of American lifestyles as well as the U.S.
healthcare system are serious consequences that were once overlooked.
Fortunately for those individuals seeking to lose weight, there are numerous
dietary, behavioral, pharmacological and surgical interventions that have proven to be
successful weight loss strategies. While all programs distinctly advertise themselves, the
basic premise of burning more calories than one consumes prevails. For individuals who
accept the challenge of taking strides toward a healthier lifestyle, weight loss and a
decrease in the risk factors for co-morbidities are the awards. However, once one reaches
an ideal weight, maintaining the new weight proves difficult. Even the most optimistic
data report that only twenty percent of those who lose ten percent or more of their initial
body weight do not regain that weight for at least one year (Wing, 2005). Since a large
proportion of people can not sustain their weight loss goals, investigating long-term
weight loss maintenance is critical to our nation’s health.
In 1999 researchers identified a hormone that may contribute to weight regain.
Ghrelin attaches to a region in the brain responsible for inducing feelings of hunger
(Wren, 2001) and the concentration of ghrelin peaks prior to the routine meal pattern of
breakfast, lunch and dinner (Cummings, 2001). Furthermore, circulating ghrelin levels
are suppressed in obese individuals and elevated in underweight individuals (Tschop,
2001; Shiiya, 2002). This inverse proportion of weight and ghrelin is intuitively logical.
An obese person does not need to consume a similar amount of calories as the
underweight individuals since the obese person has fat reserves which the body can
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utilize for energy. However, when obese individuals lose weight, some data suggest that
ghrelin levels may elevate to concentrations disproportionate to the individuals’ new
weight (Hansen, 2002). This increase in ghrelin levels triggers a stimulus for food-intake
that ultimately combats the positive results of weight loss. Although there is an emerging
body of data evaluating ghrelin levels in weight-loss maintainers in controlled laboratory
environments (Cummings, 2001; Cummings, 2002; Tanofsky-Kraff, 2007), descriptive
data collected in the non-laboratory environment are limited.
Hosoda (2004) completed the first study aimed at characterizing ghrelin stability.
While his sample size and experiments were limited, his findings have impacted the
collection and handling of blood samples used to analyze ghrelin concentrations. Today,
collecting blood samples in a laboratory setting specifies quick preservation including the
addition of 0.1 N HCl to prevent ghrelin degradation, and storage as recommended by
Hosoda (2004), and outlined by the ELISA protocols used to analyze ghrelin
concentrations in humans.
Accurate evaluation of the impact of ghrelin on weight regain in the clinical
setting requires a reliable method for the collection, processing, and storage of samples
following blood collection. While blood may be immediately preserved, processed and/or
frozen in laboratory studies, this is not the case with research occurring in the clinical
setting. The existing Millipore Human Ghrelin (Total) ELISA kit protocol for measuring
ghrelin concentrations require that blood be centrifuged thirty minutes after collection
and immediately placed in a freezer. In clinical research, collection of the sample and
transportation to a laboratory to process the sample can frequently not be completed
within the time limits of the protocols. Thus current guidelines for processing samples
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may be deterring researchers interested in evaluating ghrelin in non-laboratory settings,
and ultimately stalling the future of translational research in this field.
An extensive search in literature databases has revealed that there are no
published research reports that specifically evaluate stability of ghrelin in blood samples
in the clinical setting. Measuring ghrelin concentrations in the clinical setting makes it
virtually impossible to immediately preserve and store samples since the transportation of
centrifuges and freezers are unrealistic. Because trends in ghrelin concentrations
following attainment of goal weight will provide a foundation for interpreting the
significance of post-weight loss ghrelin concentrations, it is critical to evaluate the
accuracy of ghrelin concentrations measured in the clinical setting. To do this, ghrelin
concentrations determined according to strict observance of the existing protocol will be
compared to ghrelin concentrations measured at time periods longer than recommended.
Purpose of the Study
The objectives of this study are: (1) to analyze the serum ghrelin concentrations in
blood after storage at 4°C for thirty minutes, one hour, two hours, and three hours and
(2), to conclude based on the aforementioned findings whether a change in the
manufacturer’s protocol is warranted.
If findings suggest that blood samples collected to determine ghrelin
concentrations can indeed be stored for periods of time beyond the manufacturer’s
recommendation of thirty minutes, the effects will be far-reaching. First, the ability to
compare data collected in the clinical setting to published data obtained in the laboratory
environment will confirm that ghrelin research is indeed translational. If findings differ
between the two settings there exists the possibility that current ghrelin research is not
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capturing the spectrum of both environmental and biochemical interactions that influence
circulating ghrelin concentrations. Since no published studies have yet to investigate the
effect of storage time on mean ghrelin concentrations as detected in an ELISA assay, this
novel research will also lead to a more defined characterization of ghrelin stability.
Additionally, positive findings related to increased storage time, may attract future
researchers to this field that were once limited by storage time in research design.
While manufacturers of kit protocols, such as the one provided by Millipore, have
scientific and legal reasons for not providing the scientists using the kits with a rationale
for the processing guidelines, scientists need to understand how changes among the
protocols may affect the outcome of a study. Since no studies have yet to determine the
effect of time on mean ghrelin concentrations, it is unclear whether the few clinical
ghrelin research studies are reporting skewed data since Type II error may have been
inadvertently entered in to the study design.
Research Questions
H0: There will be no statistically significant differences in mean ghrelin
concentrations among blood samples stored for one, two, or three hours after collection
compared to the samples analyzed according to the Millipore protocol.
The aforementioned time intervals represent realistic storage times that a
researcher may experience in the clinical setting. Factors such as transportation, access to
a centrifuge, and the number of patients being evaluated are all concerns in constructing
study designs.
H0: The variables height, weight, and waist circumference will exhibit a positive,
significant correlation to mean ghrelin concentrations.
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It is expected to see that the variables which are well known for correlating to
mean ghrelin concentrations as evidenced in previous, laboratory research will remain
statistically significant in this research (r > 0.5, p < 0.1).
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CHAPTER 2
REVIEW OF RELATED LITERATURE
Researchers first identified the natural ligand, ghrelin, for the growth hormone
secretagogue receptor in 1999 (Kojima, 1999). The binding of ghrelin releases growth
hormone into the body which then binds to receptors that regulate energy balance in the
brain. Ghrelin has been identified as a hunger-stimulating hormone (Wren, 2001) and is
now considered the most important and powerful orexigenic hormone currently
recognized (Asakawa, 2001). Ghrelin is found in an active, acyl, and unactive, desacyl,
form in the human body (Hosoda, 2000) and degrades into the desacyl form. Desacyl
ghrelin is relatively stable, and can be exposed to various storage conditions including
high pH and temperature, and remain stable (Hosoda, 2004). The majority of research
(Hosoda, 2000; Cummings, 2001; Cummings, 2002) has quantified total ghrelin since
Ariyasu (2002) reported a lack in marked discrepancies between desacyl and acyl forms.
In addition, it is the only orexigenic hormone that stimulates food ingestion,
regardless of other physiologic or environmental cues for eating or satiety (Asakawa,
2001). Existing ghrelin research focuses on the biological effects of the hormone
(Cummings, 2001; Cummings, 2002; Tschop, 2001; Tschop, 2002). Research performed
by Cummings et al (2002) has provided insight into the factors that determine hunger.
This hormone may also play an important role in understanding and combating the
obesity epidemic since ghrelin concentrations are weight dependent (Tschop, 2001;
Shiiya, 2002). Hansen (2002) concluded that when an obese person loses weight, postweight loss ghrelin concentrations surpass ghrelin concentrations found in normal-weight
individuals. This biological response to weight loss may prove instrumental in
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understanding the difficulties of weight maintenance as well as the factors involved in
weight gain.
However, to date, the majority of the ghrelin research has taken place in
laboratory settings. While this setting allowed scientists to quickly process and quantify
ghrelin samples (Cummings, 2001; Cummings, 2002; Natalucci, 2005), the research takes
place under specific guidelines that are not applicable to everyday life. New translational
research aims to investigate whether previously reported ghrelin trends (Cummings,
2001; Cummings, 2002) are observable in clinical settings. In stark contradiction to
preprandial and postprandial ghrelin trends reported by Cummings et al (2001 & 2002),
in unpublished, recently completed research, Sally Miller failed to find a statistically
significant decrease between preprandial and postprandial ghrelin concentrations in the
clinical setting. The inability to find a similar trend in subjects measured in two settings
raises the issue of the importance of proper handling and processing techniques
concerning ghrelin. Current ELISA manufacturer protocols for measuring ghrelin require
that blood be centrifuged and frozen within thirty minutes of collection. In clinical
research, this is frequently not possible.
Unlike aforementioned ghrelin research that occurred in a laboratory setting,
blood samples collected in the clinical environment may sit for hours before processing
can occur. Thus, it is imperative to understand how various processing methods can
affect the stability of ghrelin.
In 2004, Hosoda revealed that ghrelin is most stable at pH 4 and recommended a
10% addition of 1 M HCl to the sample to achieve the greatest stability of the acyl side
chain. In this literature review, the research lacked a comparison between 0.05 N HCl,

8

Millipore’s recommended acidification, and 0.1 N HCl which may lead to further
preservation research.
Additionally, Hosoda (2004) recommends chilling and centrifuging the sample
within 30 minutes. Groschl (2002) and Staes (2010) both report the stability of ghrelin at
4ºC, a condition satisfied by placing collection tubes in an ice chest until processing can
occur; however, guaranteed immediate access to a centrifuge in the clinical setting is
unrealistic. While this previous research has provided an introduction in to ghrelin
stability, one must also consider the small samples sizes utilized in the studies. Hosoda
(2004) only collected samples from three participants, while Groschl (2002) has a larger
sample size of sixteen individuals. Groschl ultimately subdivided the participants to study
different storage conditions.
While the initial research into the field of ghrelin has provided current research
with important findings, there exists a myriad of research questions to be investigated.
Based on the findings of this literature review, more research into the time-sensitive
degradation of ghrelin performed using blood samples from a larger sample size is
needed to better understand how to process collection tubes before centrifugation. If
storage times do not significantly affect ghrelin concentrations over time, researchers
may begin to expand ghrelin research to incorporate the clinical setting.
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CHAPTER 3
METHODOLOGY
This research study involved the participation of human subjects, and as such the
researcher applied for IRB approval to ensure the protection of research subjects
throughout the research process. Subjects were assigned non-identifiable numbers, and
the only forms that contained the subjects’ identities were stored in a separate location
than the forms containing any identifying information such as date of birth and age.
Obtaining subject consent implied informing the subjects of the voluntary nature of
participation as well as the risks, compensation, and benefits of participation.
Recruitment for the research participants was limited to females aged 30 to 60
years. This demographic was necessary to complete other arms of the study that did not
affect the outcome of the data reported in this thesis. This study included women within
the 30 to 60 year old range, who were currently not pregnant, did not begin a weight loss
program or started a new exercise schedule within the previous thirty days. Numerous
factors such as the number of participants used in previous published literature related to
ghrelin stability, and the financial constraints of the grant, limited the number of total
research subjects to twenty six. The researcher did not use formal methods of
recruitment, but rather relied on word of mouth and both inter-and intradepartmental
emails to advertize the study among the university campus. Additionally, professors
within the University of Nevada, Las Vegas, School of Nursing informed students who
met the inclusion and exclusion criteria. As all arms of the research were novel, the
assumption was made that the demographics on the university campus were
representative of the average female.
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Collection of Data
Once a participant was consented and enrolled into the study as dictated by the
IRB approval, she reported to the Bigelow Health Science building on the University of
Nevada, Las Vegas campus in the morning following an overnight fast, which excluded
the consumption of water since previous research has shown that water does not
influence ghrelin concentrations in the body. The data of height, weight, waist
circumference, last menstrual cycle, ethnicity, marital status, regular consumption of
breakfast, medications, vitamins and/or supplements, and the presence or absence of an
exercise routine was collected. To protect against variations in different instruments, the
same Weight Watchers Conair WW70 Electronic Body Fat Scale was used to weight all
research subject to one decimal point. Height and waist circumference were measured to
the closest half inch.
Next, a certified and licensed phlebotomist used a combination 21 gauge needle
and vacutainer to collect four, 2.5 mL blood samples in to serum separator tubes. The
phlebotomist selected a vein located within the nook of the elbow or the hand of the
participant. Following venipuncture each blood sample was preserved with 1 mg/mL of
Pefabloc in accordance with the Millipore Human Ghrelin (Total) ELISA kit
recommendations to prevent ghrelin degradation. The tubes were labeled to include the
participant’s identification number.
The first tube was stored for thirty minutes according to the Millipore protocol.
The remaining three tubes were labeled “1hr,” “2hr,” and “3hr,” and stored in a cooler at
4ºC for 1, 2, and 3 hours, respectively, before being centrifuged, acidified with 0.05 N
HCl, and stored in accordance with the manufacturer recommendations. Processing of
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the blood sample was delayed for a later day, but within the guidelines of protocol
outlined by the manufacturer.
Treatment of Data
The ghrelin concentrations of each blood sample was found using the Millipore
Human Ghrelin (Total) ELISA kit (Catalog# EZGRT-87K). The samples processed
according to the Millipore protocol and the samples stored for one, two, and three hours
were analyzed using the aforementioned ELISA assay. Samples collected from each
participant at each time interval were measured in triplicate to increase the assay
reliability of the study. The final step in the ELISA assay required the use of a
spectrophotomer which analyzed the samples at different wavelengths to determine
ghrelin concentrations in pg/mL. The software associated with the spectrophotomer used
in this research produces the equation used to determine ghrelin concentration levels in
each sample. The software then provided mean ghrelin concentrations (pg/mL) for each
participant at each time interval. These data were analyzed using SPSS version 18.0
statistical programs to determine whether to reject or fail to reject the null hypotheses.
First, the variable of time was categorized as a factor, and divided in to its four
levels: baseline (30 minutes), 1 hour, 2 hour and 3 hours. Since time acted as the
independent variable in this model, a repeated measures analysis of variance test was
used to determine the effect of time on the dependent variable, mean ghrelin
concentrations. Initially, time was entered as a main effect in the model, and a crude
repeated measures analysis of variance was performed. Because the variable, time, was
found to be significant, a Least Significant Difference post hoc test allowed the
researcher to determine which time groups significantly differed from each other.
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Next, the researchers ran an adjusted analysis of variance test using the variables
that were assessed prior to the collection of the blood samples. The multicollinearity of
the variables was determined using a correlation test within the SPSS version 18.0
software. Multicollinear variables (r > 0.5, p < 0.01) were entered in to the adjusted
repeated measures analysis of variance test separately. Again, time served as the
independent variable, while mean ghrelin concentration acted as the dependent variable.
All of the other variables collected were entered in to the model as covariates. The
significance variables found while running these adjusted models were incorporated in to
a final adjusted model to determine the statistically significant variables involved in
predicting mean ghrelin concentrations.
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CHAPTER 4
FINDINGS OF THE STUDY
In twenty six females aged 30 to 60 years, the effect of time played a statistically
significant (p < 0.1) role in determining mean ghrelin concentrations. A Least Significant
Difference test determined that the mean ghrelin concentrations in samples stored for
thirty minutes, one hour, and two hour differed statistically compared to the mean ghrelin
concentrations recovered at the three hour storage time. However, when an adjusted
model incorporating the variables height, weight, waist circumference, last menstrual
cycle, ethnicity, marital status, consumption of breakfast, medications, vitamins and/or
supplements, and the presence or absence of an exercise routine was ran, variables other
than time were also significantly associated with mean ghrelin concentrations.
The final adjusted model included the statistically significant variables time, waist
circumference and presence or absence of an exercise routine, but found that the presence
or absence of an exercise routine was the only statistically significance association with
mean ghrelin concentration.
Analysis of Data
Table 1 shows the demographics of the sample population. Caucasians
represented 80.7% (n= 21) of the sample while three Hispanics constituted 11.5%, and
the remaining two subjects were Asian American. Eighteen subjects identified as
married, while five subjects were single, and three subjects were divorced. The majority
of the sample (n=17) associated into a pre-menopausal state, and 84.6% (n=22) normally
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Table 1.
Demographics and Characteristics of the Twenty-Six, Female Participants Aged 30-60
Years.
Variable
N
%
Gender
Female
Age
30-45
46-60
Height (in)
59- 66
67-72
Weight (lbs)
110-140.9
141-175.9
176-200
200-250
250-300
Waist Circumference (in)
29-35
35.5- 40
40- 45.5
Marital Status
Married
Single
Divorced
Ethnicity
Caucasian
Hispanic
Asian American
Pre-menopausal
Yes
No
Normally eat breakfast
Yes
No
Take medications
Yes
No
Take vitamins or supplements
Yes
No
Routine Exercise schedule
Yes
No

26

100

14
12

53.8
46.2

17
9

65.4
34.6

6
8
5
4
3

23.1
30.8
19.2
15.4
11.5

14
6
6

53.8
23.1
23.1

18
5
3

69.2
19.2
11.5

21
3
2

80.8
11.5
7.7

17
9

65.4
34.6

22
4

84.6
15.4

12
14

46.2
53.8

14

53.8

12

46.2

13
13

50
50
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ate breakfast. Half of the women did not have a routine exercise schedule (n=13), and
less than half reported taking either medications or supplements.
While the between subject ghrelin concentrations differ by as much as 1,200
pg/mL, the within subject concentrations grouped at similar concentrations (Table 2).
Since this analysis aimed to identify the effect of time on individual’s ghrelin
concentrations, the between subject differences did not bias the analysis. Missing data
points resulted when the ELISA assay did not detect ghrelin concentrations. As a result,
subject number 23 was removed from the dataset, and the baseline mean concentration
value of subject number 25 was substituted with the ghrelin concentration recovered at 1
hour.
The data in Table 2 are also displayed in the format of a bar graph in Figure 1.
The mean ghrelin concentrations (pg/mL) found in Table 2 served as the template to
perform the crude repeated measures analysis of variance to determine the effect of time
on mean ghrelin concentrations recovered at the baseline, one hour, two hours, and three
hours.
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Table 2.

Ghrelin Concentrations (pg/mL) of Twenty-Five Female Participants Aged 30-60 Years
Analyzed at 4ºC at Four Time Points: 30 Minutes, 1 Hour, 2 Hour, and 3 Hour.
Subject
Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
24
25
26

[Ghrelin] at 30
minutes
1618.9
995.1
686.7
381.1
479.9
1702.5
568.9
688.9
665.8
1008.4
903.0
717.5
516.9
290.2
1155.4
187.4
984.7
444.9
681.3
1025.4
252.4
963.5
373.6
331.5
2771.1

[Ghrelin] at
1 hour
1109.0
1260.3
756.3
681.9
575.4
1852.6
507.9
841.9
775.4
987.5
596.5
375.5
314.5
359.6
1498.6
380.7
1409.7
293.9
824.9
1109.1
364.8
909.1
458.8
331.5
2636.9
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[Ghrelin]at
2 hour
1615.9
1032.7
615.9
353.3
528.1
1535.5
566.1
882.3
839.5
833.6
580.8
511.8
519.3
205.8
958.3
285.8
926.9
422.1
751.6
1244.6
389.3
862.0
482.6
303.0
2537.1

[Ghrelin] at
3 hour
1119.8
391.4
529.3
383.0
472.1
1423.3
526.2
722.4
956.0
793.9
779.8
372.9
446.6
189.2
1205.6
170.2
957.3
408.0
634.1
1255.6
391.3
987.8
442.6
207.9
1981.7

Figure 1.. A bar graph depicting the mean ± 5% error bars ghrelin concentrations at each
storage time intervals: baseline (30 minutes), one hour, two hour, and three hours.
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Statistical Analysis of Research Questions
The data found in Table 2 served as the template to perform a crude repeated measures
analysis of variance to determine the effect of time on mean ghrelin concentrations at
baseline (30 minutes), one hour, two hours and three hours. Because subject number 23
did not have three out of the four data point, the data were excluded in the statistical
portion of this research. Additionally, because a baseline point from subject 25 was not
recovered, the mean ghrelin concentration found at the one hour storage time also served
as the baseline value.
As seen in Table 3, this model yielded four levels related to the factor, time:
baseline (30 minutes), one hour, two hour and three hours. Each factor contained the
dependent variable of ghrelin concentration (pg/mL). A statistically insignificant
Mauchly’s test of sphericity (p > 0.05) confirms that sphericity is maintained, and thus
directs the researcher to the correct values to interpret. These data did not have a
statistically significant Mauchly test of sphericity (Mauchly’s W = 0.630, p = 0.062).

Table 3.
The Categorization of the Four Levels of Time Generated by the Repeated Measures
ANOVA, and the Mean Ghrelin Concentrations (pg/mL) Recovered at Each Level of Time
with Their Respective Standard Deviations.
Within-Subjects Factors
Levels of time
Dependent
Mean ghrelin
Standard Deviation
Variable
concentrations (pg/mL)
[ghrelin]
1
baseline
815.8044
563.92793
2
1 hour
848.5118
558.86906
3
2 hour
791.3658
515.57120
4
3 hour
709.9261
440.04356
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This information allowed the researcher to interpret the sphericity assumed column on the
test of within subject effects which demonstrated in Table 3 that the various time points
showed a statistically significant effect of time (Table 4; F= 3.643, p= 0.017).

Table 4.
The Effect of Time is Significant in the Crude Repeated Measures ANOVA.
Test of Within-Subjects Effects
Source
F
Sig
Factor 1

Sphericity Assumed

3.643

0.017*

Note. * = p ≤ 0.1

From this test, the Least Significant Difference (LSD) post-hoc test was used to
determine which groups statistically differed from each other (Table 5).

Table 5.

Pairwise Comparisons Using the Least Significant Difference Post Hoc Test to
Determine which Storage Times Statistically Differ (p < 0.1) from Each Other.
Time level being analyzed
Compared to the time
Sig
levels
3 hour
30 minutes
.041*
1 hour
.014*
2 hour
.063*
Note.* = p ≤ 0.1

The small sample size combined with the conservative nature of this the LSD post hoc
test justified interpreting significance at p < 0.1. Mean ghrelin concentrations (Table 3) in
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the baseline, one hour, and two hour groups demonstrated statistical differences, p =
0.041, p = 0.014, and p = 0.063 respectively, from mean ghrelin concentrations in
samples stored for 3 hours (Table 5).
To avoid entering mutilcollinearity in to the model, a bivariate statistical
correlation was analyzed for the four variables: exercise, height, weight and waist
circumference. With r > 0.5 and p < 0.01, the correlations between height, weight and
waist circumference were significant (Table 6). This finding supports performing three
separate models to analyze the effect of height, weight and waist circumference. Next,
the first of three adjusted models was analyzed using a repeated measure analysis of
variance test to determine if any of the following variables significantly competed with
the effect of time on mean ghrelin concentrations:

Table 6.

Analysis of the Correlation of the Variables: Height, Weight, and Waist Circumference.
Weight
Waist
Height
Circumference
Pearson
Weight
Correlation (r)
1
.916**
.692**
Sig (p)
Waist
Circumference

Pearson
Correlation

.916**

.000

.000

1

.524**

Sig
.000
Height

Pearson
Correlation

.007

.692**

.524**

.000

.007

Sig
Note. ** = r > 0.5, and p ≤ 0.01.
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1

age, waist circumference, marital status, ethnicity, pre-menstrual status, ethnicity,
breakfast consumers, users of prescribed medications and supplements and presence or
absence of an exercise schedule in her lifestyle. Table 7 shows the test of between-subject
effects which assesses the significance of each variable entered in to the model. The

Table 7.
The Test of Between-Subjects Effects Analyzes the Effect of Covariates on the Impact of
Time in the Repeated Measures Analysis of Variance. Waist Circumference is the Only
Statistically Significant Variable.
Between-Subject Effects
Variable
F
Sig (p)
Waist circumference

3.213

0.095*

Note. * = p ≤ 0.1

small sample size of n= 25 and the exploratory nature of this research allowed the
researcher to interpret significance at p < 0.1. Table 7 shows only one variable, waist
circumference, to be significant (p = 0.095). Another repeated measures analysis of
variance test was then performed removing the variable, waist circumference, and
replacing it with the variable, weight (Table 8). None of the variable was statistically
significant (p > 0.1).

Table 8.
The Test of Between-Subjects Effects Analyzed the Effect of Potential Covariates on the
Impact of Time in the Repeated Measures Analysis of Variance.
Between-Subjects Effects
Variable
F
Sig
Weight

3.019
22

0.103

Lastly, researchers substituted the variable, height, in the repeated measures analysis of
variance test to determine what effect, if any, it had on mean ghrelin concentrations
measured at different time intervals. Table 9 shows that while the variable, height, did not
impact the dependent variable (p = 0.953) the variable, exercise, demonstrated a
significant p – value (p = 0.061).

Table 9.
The Test of Between-Subjects Effects Analyzes the Effect of Potential Covariate, Height,
on the Impact of Time in the Repeated Measures Analysis of Variance.
Between-Subjects Effects
Variable
F
Sig
Presence or absence of
exercise routine
Note. * = p ≤ 0.1.

4.056

.061*

With the findings that two variables had a statistically significant impact (p <0.1) on the
dependent variable, mean ghrelin concentration, an adjusted model was used to determine
the effect of waist circumference and exercise on
time when entered in to a repeated measures ANOVA.
The test of within-subject effect in Table 10 shows that the variable, time, is no
longer a significant variable in the model (F= 1.013, p = 0.392). While both waist
circumference and exercise proved significant predictors during the modeling process,
the between-subjects effects in Table 10 shows that only the variable, exercise, remained
statistically significant in the adjusted model (F = 4.725, p = 0.041).
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Table 10.
The Adjusted Repeated Measures Analysis of Variance Test of Within-Subject Effects
Measured the Effect of Time on Mean Ghrelin Concentrations (pg/mL) while the
Between-Subjects Effect Analyzed the Association between Potential Covariates on Mean
Ghrelin Concentrations (pg/mL).
Test of Within-Subjects Effects
Between-Subject Effects
Variable
F
Sig
Variable
F
Sig
Time

1.013

0.392

Sphericity
Assumed

Note. * = p ≤ 0.1
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Waist
Circumference

2.586

.122

Presence or
absence of
exercise routine

4.725

.041*

CHAPTER 5
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
The statistical technique used to analyze the mean ghrelin concentration over the
four storage periods of 30 minutes, one hour, two hour and three hours concluded that
there were statistically significant (p < 0.1) differences among the mean ghrelin
concentrations. In the crude model the null hypothesis was rejected and a post-hoc test
utilizing least significant difference (LSD) was implemented to determine which of the
time periods were statistically significant. Ultimately, the mean ghrelin concentrations
recovered at the three hour storage time were concluded to be statistically less than the
thirty minute, one hour and two hour mean ghrelin concentrations.
The final adjusted model revealed that exercise had the strongest association with
mean ghrelin concentrations even when adjusted for time and waist circumference. The
impact of exercise on mean ghrelin concentration plays a more significant role than time
if it is entered as a covariate in the model.
The two objectives of this study included (1) analyzing ghrelin levels in blood
samples allowed to sit for thirty minutes, one hour, two hours and three hours before
processing according to a manufacturer’s ELISA kit and (2) concluding based on the
aforementioned findings whether a change in the manufacturer’s protocol is warranted.
The results that suggest the mean ghrelin concentrations recovered after thirty minutes do
not differ statistically between samples stored for two hours accomplished this goal. This
research can serve as an initial argument for amending storage protocols within the
ELISA assay; however, future studies will need to be conducted before changes to the
existing protocol are considered.
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Discussion of Results
The demographics of the participants of this study were 80.8% Caucasian (n =
21), 11.5% Hispanic (n = 3) and two subjects or 7.7 % of the sample was Asian American
(Table 1). The majority of the participants were married (n = 18), while only 3 subjects
were divorced, and 5 were single (Table 2). The ELISA assay did not detect ghrelin
concentrations for four data points. Because three of the missing data points were found
among the samples provided by one subject, 23, the data did not contribute to the
statistical analysis of the data. For the last missing data point, the baseline mean
concentration value for subject number 25 was replaced with the mean ghrelin
concentration recovered at 1 hour. The increase at 1 hour among some of the samples
was an unexpected phenomenon. While one can only hypothesize about the increase in
ghrelin concentrations during this time interval, it is most likely the result of assay
variability, and perhaps human error involved in loading the 96 well plates. The mean
ghrelin concentrations and their standard deviations (Table 3) were depicted in a bar
graph (Figure 1), to allow for a visual representation of the task of determining if the
mean ghrelin concentrations were far enough apart to state that the mean ghrelin
concentrations statistically differed at various points in time.
When the data were entered in to the statistical software for analysis, the program
categorized the independent variable, time, in to four levels: baseline, 1 hour, 2 hour and
three hour (Table 3). Overall, the findings of the crude repeated measures ANOVA found
time to be a significant variable in mean ghrelin concentrations (Table 4). A Least
Significant Difference post hoc test revealed that mean ghrelin concentrations among the
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thirty minute, one hour and two hour time intervals did not differ by a statistically
significant amount (Table 5).
Next, the multicollinearity of the variables weight, height, waist circumference
and exercised were assessed. Because the variables waist circumference, weight and
height were found to be multicollinear ( r > 0.5, p < 0.01 ) in Table 6, these three variable
were entered in to the adjusted repeated measures ANOVA found in Tables 7, 8, and 9,
respectively. Only the variable, waist circumference, proved to be statistically significant
(Table 7). However, Table 9 which analyzed the effect of height on the model showed the
presence or absence of an exercise routine to be a statistically significant variable (p <
0.1). When the three significant variables time, waist circumference and the presence or
absence of an exercise routine were entered in to the adjusted repeated measures
ANOVA (Table 10), the presence or absence of an exercise routine proved to have the
most significant association with mean ghrelin concentrations.
While the findings of this study will benefit many researchers wishing to expand
the current realm of ghrelin research, there were some limitations that affected the final
outcome.
A study can only analyze as many subjects as the funding can support, and this
study is a testament to those financial restrictions. While a sample size of twenty five
subjects was larger than any previously reported sample size used to study ghrelin
stability, it may not be large enough to determine the actual trends of ghrelin degradation
over time.
Additionally, the sample size is too small to make generalizations about the
overall population; however, the findings supported here provide an initial step in
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learning more about the effects of storage conditions of this appetite stimulating
hormone.
Participants were asked to complete this study while in a fasted state, and it is
possible that ghrelin concentrations could not be recovered in subject number 23 due to
consumption of food or beverages before the blood collection. In a more ideal setting, the
researcher would be able to confirm that food intake does not occur before taking
samples to ensure that ghrelin concentrations can be detected.
Furthermore, while the goal was to centrifuge and acidify blood samples at the
indicted times, there were occasions when the processing of samples was delayed by five
to ten minutes. In future studies, the ability to be precise while processing the sample
should be taken in to account. In addition, the need to minimize human error and increase
assay validity as other aspects to be considered in future studies.
Conclusions and Recommendations for Further Study
The crude repeated measures ANOVA showed that mean ghrelin concentrations
at thirty minutes, one hour and two hour did not differ statistically. This finding could
allow future researchers wishing to observe ghrelin in the non-traditional, clinical setting,
to go in to the field to collect samples from a broad range of subjects. Prior to these
findings, researchers were limited to just thirty minutes to collect and preserve the
sample, as well as transport the specimen to a centrifuge to be processed. The crude
findings alone will positively impact the field of translational ghrelin research.
With increased storage times scientists studying ghrelin can design and implement
research in the clinical setting. Collecting data in this environment will give scientists
greater insight into the effect ghrelin has on individuals acting in their routine settings.

28

The ability to perform translational research will positively impact the current knowledge
base regarding ghrelin, and its effect on obesity. Ultimately, future research on ghrelin
could prove instrumental in helping individuals maintain weight loss, prevent obesity,
and reduce the risk of co-morbidities related to this epidemic.
The field of research related to ghrelin is vast, and results of new experiments are
continually being published. In this specific area a similar study could be expanded to
include both female and male participants over the age of 18, and process samples more
frequently, such as every fifteen minutes, instead of the thirty and sixty minute intervals
used in this research. Additionally, an increased sample size may elucidate the effect of
variables that researchers expected to be significant, such as waist circumference, and
weight. As researchers learn more about the optimal preservation of ghrelin, they can
continue to lift design limitations that have previously constricted research of this
hormone.
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APPENDIX 1
IRB APPROVAL
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APPENDIX 2
MILLIPORE HUMAN GHRELIN (TOTAL) ELISA KIT PROTOCOL
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